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Research Article
Myeloid cell deficiency of p38c/p38d protects against
candidiasis and regulates antifungal immunity
Dayanira Alsina-Beauchamp1, Alejandra Escós1 , Pilar Fajardo1, Diego González-Romero1,
Ester Díaz-Mora1, Ana Risco1, Miguel A Martín-Serrano1, Carlos del Fresno2, Jorge Dominguez-Andrés1,
Noelia Aparicio1, Rafal Zur1, Natalia Shpiro3, Gordon D Brown4, Carlos Ardavín1, Mihai G Netea5,
Susana Alemany6, Juan J Sanz-Ezquerro7 & Ana Cuenda1,*
Abstract
Candida albicans is a frequent aetiologic agent of sepsis associated
with high mortality in immunocompromised patients. Developing
new antifungal therapies is a medical need due to the low effi-
ciency and resistance to current antifungal drugs. Here, we show
that p38c and p38d regulate the innate immune response to
C. albicans. We describe a new TAK1-TPL2-MKK1-ERK1/2 pathway
in macrophages, which is activated by Dectin-1 engagement and
positively regulated by p38c/p38d. In mice, p38c/p38d deficiency
protects against C. albicans infection by increasing ROS and iNOS
production and thus the antifungal capacity of neutrophils and
macrophages, and by decreasing the hyper-inflammation that
leads to severe host damage. Leucocyte recruitment to infected
kidneys and production of inflammatory mediators are decreased
in p38c/d-null mice, reducing septic shock. p38c/p38d in myeloid
cells are critical for this effect. Moreover, pharmacological inhibi-
tion of p38c/p38d in mice reduces fungal burden, revealing that
these p38MAPKs may be therapeutic targets for treating C. albi-
cans infection in humans.
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Introduction
Candida (C.) albicans is a harmless component of the human micro-
biota; however, under conditions in which tissue homeostasis is
altered and host defence is compromised, C. albicans becomes a
pathogen and can invade the mucosa reaching the bloodstream and
causing systemic infection (Brown et al, 2012; Netea et al, 2015;
Kim, 2016). Invasive fungal infection by Candida species (spp) is a
serious health concern, particularly for immunocompromised
patients (Brown et al, 2012; Kim, 2016). Among Candida spp, the
sepsis caused by C. albicans is one of the most frequent in hospital
intensive care units in patients with AIDS or auto-immune diseases
and in those undergoing anti-cancer chemotherapy or organ trans-
plantation (Wisplinghoff et al, 2006; Brown et al, 2012; Kullberg &
Arendrup, 2015, 2016). In the last years, the cases of invasive
candidiasis have increased and the mortality rate associated with it
is higher than 40%, even in patients receiving antifungal therapy
(Brown et al, 2012; Kullberg & Arendrup, 2015, 2016). The develop-
ment of novel antifungal drugs is insufficient, and only a small
number are currently used in clinical applications. Moreover, anti-
fungal drug resistance is worryingly growing (Kim, 2016). Therefore,
understanding how the immune response towards C. albicans is
mounted and knowing the mechanism of immune resistance to
fungal spread is crucial to develop novel therapeutic strategies to
combat candidiasis.
Macrophages and neutrophils are at the first line of defence
against C. albicans and are important for the activation and regula-
tion of the innate immune response. These cells express pattern
recognition receptors (PRR) that recognize molecules on the surface
of the invading pathogens, called pathogen-associated molecular
patterns (PAMP; Lee & Kim, 2007). Activation of PRRs on innate
immune cells leads to the secretion of cytokines and other mediators
that promote the elimination of infectious agents and induction of
tissue repair (Lee & Kim, 2007). The best-characterized PRRs are the
Toll-like receptors (TLR; Takeda et al, 2003) and the C-type lectin
receptors (CLR; Netea et al, 2008). Both are involved in C. albicans
recognition by binding to different molecules on the fungal surface.
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In macrophages, TLR2 and TLR4 recognize phospholipomannans,
whereas the CLR Dectin-1 recognizes b-glucans (Netea et al, 2015).
Upon fungus recognition, the stimulation of these receptors triggers
the activation of NF-jB and MAPK pathways, which are crucial to
generate the immune responses (Lee & Kim, 2007; Geijtenbeek &
Gringhuis, 2009; Takeuchi & Akira, 2010). The three major MAPK
pathways activated by PRRs are those leading to the activation of c-
Jun N-terminal Kinase (JNK), p38MAPK and extracellular signal-
regulated kinase 1/2 (ERK1/2; Lee & Kim, 2007; Gaestel et al,
2009).
There are four p38MAPK isoforms, p38a, p38b, p38c, and p38d,
encoded by different genes, which are activated in response to a
range of cell stresses and in response to inflammatory cytokines
(Cuenda & Sanz-Ezquerro, 2017). Among them, p38a is crucial for
the synthesis of pro-inflammatory molecules and for the regulation
of the immune response (Gaestel et al, 2009). Also, p38c and p38d
(p38c/p38d) have recently been shown to play important roles in
regulating cytokine production, T-cell activation, insulin resistance,
and in tumorigenesis associated with inflammation (Risco et al,
2012; Criado et al, 2014; Esco´s et al, 2016; Cuenda & Sanz-
Ezquerro, 2017). Although several studies have demonstrated that
p38c/p38d are involved in inflammatory processes, the functional
roles of these kinases in the innate immune responses have not been
fully characterized. In particular, the role of p38c/p38d in C. albi-
cans infection is completely unknown. We have therefore investi-
gated the role of p38c/p38d on the C. albicans-mediated activation
of macrophages and in the early innate response against fungal
infection, using a mouse model of systemic candidiasis in which the
kidney is the main target organ (Lionakis et al, 2013). Here we
report that p38c/p38d are important in modulation of host antifun-
gal immune response, since their deletion, particularly in myeloid
cells, protects against C. albicans infection and increases fungal
elimination by neutrophils and macrophages. We also identified a
novel signalling pathway downstream of Dectin-1 in which TAK1-
IKKb-TPL2 are essential for ERK1/2 activation and cytokine produc-
tion in mouse macrophages and human monocytes. TPL2 is the
upstream kinase that mediates MKK1-ERK1/2 activation after TLR
stimulation, whose protein level is regulated by p38c/p38d (Risco
et al, 2012). Finally, we show that in vivo pharmacological p38c/
p38d inhibition, using kinase inhibitors, reduces the symptoms of
C. albicans systemic infection and increases the clearance of the
fungus in the kidney. This study could be the basis for designing
novel therapeutic strategies in invasive candidiasis using p38c/p38d
as targets.
Results
p38c/p38d regulate Candida albicans-induced cytokine
production
To investigate the role of p38c/p38d in C. albicans infection, we
assessed inflammatory cytokine and chemokine mRNA levels in
response to heat-killed C. albicans (HK-Ca) in WT and p38c/d/
bone marrow-derived macrophages (BMDM) in vitro. Macrophages
are one of the main cells that come in contact with the fungus
early after infection in candidiasis (Lionakis et al, 2013). HK-Ca
stimulation in p38c/d/ BMDM had no effect in the mRNA
expression of TNFa and IL-6, whereas IL-1b, IL-10, KC, MIP-2 and
CCL2 mRNA expression was markedly reduced as compared to
that in WT BMDM (Fig 1A), indicating the need of these p38
kinases for cytokine and chemokine production in the response to
C. albicans.
To assess whether p38c/p38d loss altered the signalling response
involved in cytokine production, we analysed changes in NF-jB and
MAPK (p38a, ERK1/2, JNK) pathways activation in response to
C. albicans in p38c/d/ and WT BMDM. We found that p38c/p38d
deletion did not have a significant effect on the activation of p38a
and the NF-jB pathways, although the activation of these pathways
was more sustained in WT than in p38c/d/ BMDM (Fig 1B). In
contrast, ERK1/2 phosphorylation was substantially reduced in
p38c/d-null BMDM as compared to WT BMDM (Fig 1B). We did not
detect significant HK-Ca-induced phosphorylation of JNK1/2 either
in WT or p38c/d/ BMDM (Fig 1B).
To determine the mechanism by which ERK1/2 pathway activa-
tion is impaired in p38c/d/ BMDM after C. albicans infection, we
examined ERK1/2 phosphorylation in response to specific ligands
for each C. albicans-activated receptor in macrophages. We have
previously reported that p38c/p38d positively regulate TLR4-
induced ERK1/2 activation and cytokine production by controlling
the steady-state levels of the MKK kinase TPL2 in macrophages
(Risco et al, 2012), which is not expressed in p38c/d/ cells
(Fig 1B). p38c/d deletion impaired ERK1/2 pathway activation in
response to both the TLR2/6 ligand tripalmitoylated lipopeptide
(Pam3Cys) and the TLR4 ligand LPS (Fig 1C). Accordingly, the acti-
vation of ERK1/2 pathway in response to unmethylated CpG
oligonucleotide (ODN, TLR9-ligand), Imiquimod (TLR7-ligand) and
poly I-C (TLR3-ligand), which is mediated by TPL2, was also
impaired in p38c/d/ macrophages (Appendix Fig S1A and B). In
contrast, ERK1/2 activation in response to PMA, which is dependent
on Raf-1, another MKK1/2 kinase (Wellbrock et al, 2004), and
TPL2-independent (Beinke & Ley, 2004) was unaffected
(Appendix Fig S1B). p105 NF-jB1, JNK1/2 and p38a were still phos-
phorylated in response to TLR ligands in p38c/d-null macrophages
(Appendix Fig S1C). All these data demonstrate that p38c/p38d
regulate ERK1/2 activation triggered by TLRs. Nonetheless, we also
examined the contribution of Dectin-1 to cytokine production and
ERK1/2 pathway activation in BMDM by stimulating with Curdlan,
a purified b-glucan that mimics fungal stimulation in innate immune
cells (Gantner et al, 2003). The stimulation of p38c/d-null macro-
phages with Curdlan resulted in decreased IL-1b production
(Fig 1D) and decreased MKK1-ERK1/2 activation as compared to
WT BMDM (Fig 1E). p38a, JNK1/2 and p105 NF-jB1 were phospho-
rylated in response to Curdlan in WT and p38c/d/ macrophages
(Fig 1E).
We confirmed the specificity of Curdlan as a Dectin-1 ligand by
examining ERK1/2 activation in MyD88/, Dectin1/ BMDM and
also using the Syk inhibitor PRT062607 (Spurgeon et al, 2013) in WT
BMDM. TLRs signal via the adaptor molecule MyD88, whereas Dectin-
1 signalling is mediated by the recruitment of the tyrosine kinase Syk
(Underhill, 2007; Reid et al, 2009; Takeuchi & Akira, 2010). Curdlan,
HK-Ca and LPS (used as control) induced ERK1/2 phosphorylation in
WT macrophages. The activation of ERK1/2 in MyD88/ BMDMwas
blocked in response to LPS, whereas in response to Curdlan was not
affected and in response to HK-Ca was partially impaired, compared to
WT BMDM (Appendix Fig S1D). Furthermore, in Dectin1/ BMDM,
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ERK1/2 activation by Curdlan was blocked, by HK-Ca was partially
inhibited and by LPS was not affected (Appendix Fig S1E). In WT
macrophages pre-treated with the compound PRT062607, the phos-
phorylation of ERK1/2 was significantly inhibited in response to Curd-
lan and was not affected in response to LPS (Appendix Fig S1F). These
results confirm that, in macrophages, the activation of ERK1/2
induced by Curdlan was mediated by Dectin-1-Syk signalling and not
by TLRs, whereas ERK1/2 activation in response to HK-Ca was also
partially induced via TLR-MyD88 signalling.
TAK1-IKKb-TPL2 activation is essential for Dectin-1 signalling
in macrophages
Since TPL2 was not expressed in p38c/d/ cells (Fig 1B and E),
our results suggest that the kinase TPL2 regulates ERK1/2 activa-
tion triggered by Dectin-1. To investigate this in more depth, we
used TPL2/ BMDM. In these cells, ERK1/2 activation was abol-
ished in response to LPS, Curdlan, HK-Ca and Zymosan, which
activates Dectin-1 and TLR2 in macrophages (Brown et al, 2003;
TNF
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Figure 1. Cytokine production and ERK1/2 activation is impaired in p38c/p38d-null BMDM in response to TLRs and Dectin-1 ligands.
A BMDM from WT or p38c/d/ mice were exposed to HK-Ca (1 × 106 CFU/ml) for the indicated times. Relative mRNA expression was determined by qPCR for TNFa,
IL-6, IL-1b, IL-10, KC, MIP-2 and CCL2. Results were normalized to b-actin mRNA expression, and x-fold induction was calculated relative to WT expression at 0 h.
Data show mean  SEM from one representative experiment of two in triplicate, with similar results. Only significant results are indicated, *P ≤ 0.05 relative to WT
BMDM exposed to HK-Ca, at each time point. Parametric, unpaired t-test.
B BMDM from WT or p38c/d/ mice were stimulated as in (A). Cell lysates (50 lg) were immunoblotted with antibodies to active phosphorylated ERK1/2 (P-ERK1/2),
p38a (P-p38a) or JNK1/2 (P-JNK1/2), or to phosphorylated p105 NF-jB1 (P-p105). Total protein levels for the above proteins and for TPL2 were also measured as
loading controls. Representative immunoblots from three independent experiments are shown.
C BMDM were stimulated 200 ng/ml Pam3Cys or 100 ng/ml LPS. Cell lysates were immunoblotted with the indicated antibodies. Representative immunoblots from
three independent experiments are shown.
D BMDM were exposed for 1 h to 10 lg/ml Curdlan. Relative mRNA expression was determined by qPCR for IL-1b. Results were normalized and fold induction
calculated as in (A). Data show mean  SEM from one representative experiment of two in triplicate, with similar results. Only significant results are indicated,
*P ≤ 0.05 relative to WT BMDM exposed to Curdlan. Parametric, unpaired t-test.
E BMDMwere stimulated with 10 lg/ml Curdlan and cell lysated immunoblotted as shown. Representative immunoblots from three independent experiments are shown.
Source data are available online for this figure.
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Fig 2A), confirming that TPL2 mediates ERK1/2 activation not only
downstream of TLR but also downstream of the receptor Dectin-1.
Consistently, we found that pharmacological blockade of TPL2 by
the compound C34 (Green et al, 2007; Wu et al, 2009;
Appendix Fig S2A) and of MKK1 by the inhibitor PD184352 (Bain
et al, 2007) inhibited Curdlan and HK-Ca-induced ERK1/2 activa-
tion in WT BMDM (Fig 2B and Appendix Fig S2B). C34 also
reduced IL-1b mRNA production in Curdlan- and HK-Ca-activated
WT BMDM, but not in p38c/d/ BMDM (Fig 2C and
Appendix Fig S2C), supporting the important role of p38c/p38d-
TPL2 in Dectin-1 signalling. This is the first time that a role for
TPL2 in ERK1/2 activation triggered by Dectin-1 signalling is
described.
TPL2 activation is regulated by IKKb in TLR-stimulated macro-
phages (Gantke et al, 2011; Roget et al, 2012; Ben-Addi et al,
2014). Moreover, the kinase TAK1 is required for the activation of
IKKb in the canonical IKK complex leading to TPL2-MKK1-ERK1/2
activation (Cohen, 2014). Therefore, to investigate whether the
TAK1-IKK signalling pathway was involved in the activation of
ERK1/2 induced by Dectin-1, we treated macrophages with the
highly selective ΙΚΚb inhibitor BI605906 (Clark et al, 2011) or
with the potent TAK1 inhibitor, NG25 (Dzamko et al, 2012).
BMDM pre-treatment with BI605906 or NG25 blocked Curdlan
from inducing ERK1/2 activation (Fig 2D and E). Accordingly,
BI605906 and NG25 also impaired ERK1/2 phosphorylation in
response to HK-Ca (Fig 2E and F). NG25 also inhibited Curdlan-
and HK-Ca-induced phosphorylation of p105 NF-jB1 and in
response to LPS the ERK1/2 and p105 NF-jB1 phosphorylation
(Fig 2E). All our data together indicate that p38c/p38d positively
modulate TPL2 levels and that TAK1-IKKb-TPL2 regulate MKK1-
ERK1/2 activation in both Dectin-1 and TLR pathways in macro-
phages (Fig 2G).
Additionally, we studied the implication of TPL2 in C. albicans
response in human peripheral blood mononuclear cells (PBMCs)-
derived monocytes. In these cells, Dectin-1 is an important receptor
for the immune sensing of C. albicans, since incubation with lami-
narin, a specific Dectin-1 inhibitor, largely decreases cytokine
production in response to the fungus (Toth et al, 2013). Monocytes
were pre-treated with the TPL2 inhibitor C34 or the p38a/b inhibitor
SB203580, as control, and then stimulated with HK-Ca. As expected,
HK-Ca-induced ERK1/2 phosphorylation was reduced to the basal
levels by pre-incubation with C34 (Appendix Fig S2D). HK-Ca-
induced expression of TNFa, IL-6 and IL-10 was impaired by C34,
whereas SB203580 only partially blocked IL-10 production
(Appendix Fig S2E), supporting the conclusion that in vitro, C. albi-
cans-induced cytokine production is dependent on TPL2 activity
also in human monocytes.
p38c/p38d deletion protects from Candida albicans infection
Since inflammation is central to candidiasis, we aimed to define
the role of p38c/p38d in the host defence against disseminated
candidiasis as mirrored by an intravenous challenge model of
C. albicans infection. This is an established model of systemic
candidiasis, in which the kidneys are the primary target organs;
mice develop renal failure and septic shock, and this recapitulates
the progressive sepsis seen in humans during severe clinical cases
(Spellberg et al, 2005). We first compared the survival of p38c/
p38d-deficient (p38c/d/) mice and control WT mice to fungal
infection. We observed that the lack of p38c/p38d caused a
remarkable protection to infection (Fig 3A). To determine whether
the effect in survival was due to p38c/p38d in myeloid cells, we
also analysed mice with myeloid cell-specific p38c/p38d deletion
(LysM-p38c/d/; Zur et al, 2015). In agreement with the observa-
tion in p38c/d/ mice, the survival of LysM-p38c/d/ mice was
significantly increased compared with control mice after C. albi-
cans infection (Fig 3A). The effect of p38c/p38d deletion on mouse
survival was probably due to the decreased load of C. albicans in
the organs; accordingly, the fungal burden in p38c/d/ and
LysM-p38c/d/ kidneys was significantly lower than in WT
control mice (Fig 3B and Appendix Fig S3). When we analysed
C. albicans dissemination after intravenous injection, we found
that the fungus was rapidly cleared from the bloodstream in all
genotypes (Appendix Fig S3). Although the clearance in WT mice
bloodstream was markedly slower than in p38c/d/ and LysM-
p38c/d/ mice, the fungal burden in spleen, liver and brain was
similar in all mice (Appendix Fig S3). In kidney, fungal burden
was similar in all mice at day 1, whereas in p38c/d/ and LysM-
p38c/d/ mice, the fungal burden was slightly lower at day 2 and
significantly lower at day 3 of C. albicans injection than in WT
mice (Appendix Fig S3). Histological analysis of kidney sections
revealed that at day 3 post-infection WT mice showed evident
growth of C. albicans forming hyphae, whereas kidneys from
p38c/d/ and LysM-p38c/d/ mice displayed nearly unde-
tectable hyphae formation (Fig 3C). These results indicate that
p38c/p38d, particularly in myeloid cells, increase resistance to
C. albicans infection.
Since p38c/p38d regulate TPL2 protein levels in macrophages,
we then assessed the role of TPL2 in the response to C. albicans
in vivo. Loss of TPL2 did not protect against fungal infection, as
TPL2+/+ and TPL2/ mice survival was similar (Fig 3D). We
also found that TPL2 deletion led to a small increase in fungal
burden in the kidney, when compared with TPL2+/+ kidney
(Fig 3E). Histological analysis of kidney sections confirmed these
results; both WT and TPL2/ mice showed extensive growth of
C. albicans forming hyphae (Fig 3C). These data show that TPL2
deletion does not protect against C. albicans infection and suggest
that in vivo p38c/p38d diminish fungal infection independently of
TPL2.
p38c/p38d deletion decreased the inflammatory response against
Candida albicans infection
To address the possibility that increased survival of p38c/d-deficient
mice to C. albicans infection could be due to effects on the
inflammatory response, we quantified the levels of pro-inflamma-
tory cytokines at early time points of infection. p38c/d/ mice
showed a significant reduction of TNFa and IFNc serum levels
compared to WT mice (Appendix Fig S4A). IL-1b production was
slightly reduced in p38c/d/ mice compared to control
(Appendix Fig S4A). Accordingly, in kidney, TNFa, IL6 and IL-1b
mRNA levels were significantly reduced in p38c/d/ and LysM-
p38c/d/ mice at day 1 post-infection, compared to WT mice
(Fig 4A). The reduction in cytokine mRNA production was more
pronounced in LysM-p38c/d/ than in p38c/d/ mice. In TPL2/
mice infected with C. albicans, the production of cytokines in the
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Figure 2. ERK1/2 activation is mediated by TPL2 in Dectin-1 signalling.
A BMDM from TPL2+/+ or TPL2/ mice were stimulated with 1 × 106 CFU/ml HK-Ca, 10 lg/ml Curdlan or 50 lg/ml Zymosan for 1 h, or with 100 ng/ml LPS for
30 min. Cell lysates were immunoblotted with the indicated antibodies. Representative immunoblots are shown. Bands from three experiments were quantified using
the Odyssey infrared imaging system (bottom), and data show mean  SEM from two experiments in duplicate. ***P ≤ 0.001. Parametric, unpaired t-test.
B WT BMDM were incubated for 1 h with or without 5 lM C34 or 2 lM PD184352, and then stimulated for 1 h with 10 lg/ml Curdlan. Representative immunoblots
from two independent experiments are shown.
C BMDM were incubated for 1 h with DMSO or with 5 lM C34, and then exposed for 1 h to 10 lg/ml Curdlan. Relative mRNA expression was determined by qPCR for
IL-1b. Results were normalized and fold induction calculated. Data show mean  SEM from one representative experiment of two in triplicate, with similar results.
ns, not significant, *P ≤ 0.05 relative to WT BMDM exposed to Curdlan. Parametric, unpaired t-test.
D WT BMDM were incubated for 1 h with or without 5 lM C34 or 10 lM BI605906 and then stimulated with Curdlan as in (B). Representative immunoblots from four
independent experiments are shown.
E WT BMDM were incubated for 1 h with DMSO or with 2 or 5 lM NG25 and then stimulated with HK-Ca, Curdlan or LPS as in (A). Representative immunoblots from
two independent experiments are shown.
F WT BMDM were incubated for 1 h in the absence or the presence of 5 lM C34 or 10 lM BI605906, and then stimulated for 1 h with 1 × 106 CFU/ml HK-Ca. Cell
lysates were immunoblotted as indicated. Representative blots from two independent experiments are shown.
G Schematic representation of the Dectin-1 signalling pathways involved in ERK1/2 activation, which is controlled by TAK1-IKK-TPL2 in HK-Ca and Curdlan-stimulated
macrophages. The activation of the TAK1 complex (TAB 1-TAK1-TAB 2/3) and of the IKK pathway (Cohen, 2014) might be mediated by TRAF6, which binds to the
CARD9/BCL-10/MALT1 complex downstream of Syk (Geijtenbeek & Gringhuis, 2009). TLR stimulation by HK-Ca also triggers the activation of TAK1-IKK-TPL2 via
MyD88. p38c and p38d regulate TPL2 steady-state levels, which is in a complex with ABIN-2 and p105 (Gantke et al, 2011).
Source data are available online for this figure.
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kidney was not reduced compared to TPL2+/+ mice (Appendix Fig
S4B). IL6, TNFa, and IL-1b mRNA levels in TPL2/ kidney were
significantly higher than in TPL2+/+ mice (Appendix Fig S4B) indi-
cating that in vivo TPL2 does not mediate cytokine production
downstream of p38c/p38d in response to C. albicans.
We also analysed, by flow cytometry, different leucocyte cell
types infiltrating the infected kidney of WT, p38c/d/ and LysM-
p38c/d/ mice, at days 0, 1 and 3 after C. albicans infection. The
number of total renal-infiltrating leucocytes (CD45+ cells) increased
with the infection and was significantly lower in p38c/d/ and
LysM-p38c/d/ mice than in WT at day 3 post-infection (Fig 4B).
Next, we determined the recruitment of major leucocyte types
involved in inflammation: macrophages, neutrophils and T cells.
We found that C. albicans infection caused an increase in the
amount of F4/80+ macrophages and Ly6G+ neutrophils in all geno-
types after infection (Fig 4B). Macrophages and neutrophils are a
major fraction of the total CD45+ population after C. albicans infec-
tion (Fig 4B). The amount of macrophages and neutrophils accumu-
lated in p38c/d/ and LysM-p38c/d/ kidney 3 days after
C. albicans infection was significantly lower than in WT, although
the effect in neutrophil recruitment was more pronounced than in
macrophages recruitment (Fig 4B). The reduction in macrophages
and neutrophils recruitment was more evident in LysM-p38c/d/
than in p38c/d/ mice. CD4+, but not CD8+, T lymphocyte
amount increased after C. albicans infection; however, they remain
a minor percentage of the total leucocyte population and the dif-
ference in T-cell accumulation was minimal between WT, p38c/
d/ and LysM-p38c/d/ mice (Appendix Fig S4C). We further
confirmed the decrease in F4/80+ macrophages and Ly6G+ neutro-
phils recruitment using an intraperitoneal C. albicans model (Netea
et al, 1999). As expected, we found a significant reduction in peri-
toneal neutrophil recruitment in p38c/d/ and LysM-p38c/d/
mice compared to control; however, the recruitment of F4/80+
macrophages was clearly reduced only in LysM-p38c/d/
peritoneum (Fig 4C).
The decrease in leucocyte recruitment in p38c/d/ and LysM-
p38c/d/ kidneys suggests reduced chemokine expression. Thus,
CCL2, MIP-2 and KC mRNA levels were clearly lower in the kidney
of p38c/d/ and LysM-p38c/d/ mice than in WT animals at day
1 post-infection (Fig 4D). Together, these findings suggest that
p38c/p38d are involved in the early inflammatory response to
C. albicans by modulating cytokine and chemokine production and
the recruitment of leucocytes into the C. albicans-infected kidney.
We then treated WT and p38c/d/ mice with ibuprofen, which is a
commonly used antiinflammatory compound (Vilaplana et al,
2013). Ibuprofen treatment reduced kidney C. albicans load and
neutrophil recruitment in WT mice to similar levels than the loss of
p38c/p38d (Appendix Fig S5A and B). In p38c/d/ mice, the treat-
ment with ibuprofen did not cause a major effect in fungal burden
or the recruitment of neutrophils after C. albicans infection
(Appendix Fig S5A and B). When we examined the effect of ibupro-
fen on the survival of C. albicans-infected WT and p38c/d/ mice,
we found that at early times the antiinflammatory compound caused
a marked protection and an increase in the survival of WT mice
(Appendix Fig S5C). Ibuprofen, however, did not affect p38c/d/
mice survival (Appendix Fig S5C). These results support that p38c/
p38d are involved in modulating an early deleterious inflammatory
response to C. albicans.
p38c/p38d deficiency increases macrophages and neutrophils
antifungal activity
Macrophages and neutrophils regulate bacterial and fungal infec-
tions by phagocytosis and killing mechanisms (Vonk et al, 2002;
Nicola et al, 2008; Lionakis et al, 2013). The production of highly
reactive nitrogen and oxygen species (RNS and ROS) is one of the
main mechanisms used by phagocytes to control fungal infection
and is essential for C. albicans killing (Nicola et al, 2008; Naglik
et al, 2014). Our data suggest that C. albicans can be eliminated
more efficiently in p38c/d-null mice than in WT controls. We then
analysed whether or not the p38c/p38d deletion affected the ability
of macrophages to express inducible nitric oxide synthase (iNOS),
which generates nitric oxide (NO) from arginine and oxygen and is
expressed after the activation of phagocytic cells. iNOS mRNA
expression was upregulated upon HK-Ca stimulation in both WT
and p38c/d/ BMDM; however, the levels in p38c/d/ cells were
markedly higher than in WT (Fig 5A). We also found that the loss
of p38c/p38d significantly enhanced the production of reactive
oxygen species (ROS) by C. albicans-stimulated macrophages
(Fig 5B). We then performed an ex vivo killing assay, co-culturing
C. albicans with BMDM, to assess whether the enhanced iNOS and
ROS levels in p38c/d/ cells correlated with an increase in their
Candida-killing potency. Fungal phagocytosis by BMDM was similar
in both genotypes (Appendix Fig S6A), indicating that the recogni-
tion of C. albicans is not affected in p38c/d/ cells. Nonetheless,
p38c/d/ macrophages were significantly more efficient in the
killing of live C. albicans than WT cells (Fig 5C). The ROS produc-
tion and the fungal-killing capacity of p38c/d/ neutrophils were
also markedly higher compared to WT control neutrophils (Fig 5D
and E), further indicating that p38c/p38d negatively impact the abil-
ity of phagocytic cells to clear the C. albicans, which is important
for mice survival in the candidiasis model.
To examine whether the observed differences in ROS production
in vitro were also seen in vivo in immune cells that are recruited to
▸Figure 3. p38c/p38d deletion decreases Candida albicans infection in mice.A, B WT, p38c/d/ and LysM-p38c/d/ mice were infected with 1 × 105 CFU C. albicans. (A) Survival monitored as indicated. Data are presented as a Kaplan–Meier
plot from two independent experiments (n = 20 mice per genotype). Two-way ANOVA using GraphPad Prism software. (B) Kidney fungal burden at day 3 post-
infection. Data are expressed as CFU/g kidney (mean  SEM). Each symbol represents an individual mouse. ns, not significant, *P ≤ 0.05, **P ≤ 0.01 and ***P ≤
0.001 relative to WT mice. Parametric, unpaired t-test.
C Representative PAS-haematoxylin staining of kidney sections from mice at day 3 post-infection. Bottom panels are high magnification of the area marked by a
dotted square in the top panels. Scale bars are 100 lm.
D, E TPL2+/+ and TPL2/ mice were infected with C. albicans as in (A). (D) Death was monitored. Data are a summary of two independent experiments (n = 12 mice per
genotype). (E) Kidney fungal burden at day 3 post-infection with 1 × 105 CFU. Each symbol represents an individual mouse. Data are expressed as CFU/g kidney
(mean  SEM). *P ≤ 0.05 relative to WT mice. Two-way ANOVA using GraphPad Prism software.
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the inflammatory sites, we infected intraperitoneally WT and p38c/
d/ mice with C. albicans and 24 h later measured ROS production
both without (Fig 5F) or with (Fig 5G) re-stimulation in vitro with
C. albicans. Cells that infiltrate the intraperitoneal cavity of p38c/
d/ mice produced significantly more ROS than cells from WT mice
(Fig 5F and G). Additionally, the induction of iNOS mRNA produc-
tion in the kidney of C. albicans-infected mice was markedly higher
in p38c/d/ than in WT mice (Fig 5H). All these data suggest that
the protective effect of p38c/d deficiency against fungal infection is
due to increased killing of C. albicans.
To investigate whether the increased levels of ROS observed in
p38c/d/ BMDM contribute to antifungal activity of these cells
against C. albicans, we treated them with the antioxidant compound
N-acetylcysteine (NAC; Victor et al, 2003). NAC reduced both ROS
levels and C. albicans killing in vitro (Appendix Fig S6B and C).
Moreover, we found that in vivo the antioxidant compound
decreased the survival of p38c/d/-infected mice to similar levels
than those in WT-infected mice (Fig 5I). These results indicate that
the increase in ROS production observed in p38c/d/ mice is
important for the antifungal activity and protection against C. albi-
cans infection.
Pharmacological inhibition of p38c/p38d ameliorates Candida
albicans infection
Based on our data, we hypothesized that p38c/p38d inhibition
in vivo might improve the outcome of C. albicans infection and
provide evidence for a new therapeutic approach. We performed
experiments treating mice with the p38MAPK inhibitor BIRB796.
Since BIRB796 inhibits all p38 isoforms (Kuma et al, 2005), we
also used as control the compound SB203580, which only blocks
p38a/p38b activity (Kuma et al, 2005; Bain et al, 2007), so we
could determine which effect was caused by p38c/p38d or by
p38a/p38b inhibition. We first checked whether these compounds
inhibit p38MAPKs in the kidney of infected mice. Both compounds
worked equally well in vivo as shown by the reduction in TNFa
mRNA expression in the kidney of C. albicans-infected mice
(Appendix Fig S7A) and inhibited p38a, as shown by the loss of
its phosphorylation (Appendix Fig S7B). Moreover, BIRB796, but
not SB203580, was able to decrease the phosphorylation of p38c
and p38d induced after C. albicans infection (Appendix Fig S7C).
Notably, BIRB796 treatment significantly reduced kidney fungal
load at day 3 (Fig 6A), but not at day 1 (Appendix Fig S7D) in
WT mice. This fungal burden reduction was similar to that
observed in p38c/d/ mice (Appendix Fig S7E). BIRB796 treat-
ment did not affect C. albicans load in p38c/d/ mice
(Appendix Fig S7E). SB2013580 did not affect C. albicans growth
in the kidney compared to control mice treated with the vehicle
DMSO (Fig 6A). Consequently, BIRB796 treatment led to a higher
fungal-induced iNOS mRNA levels compared to controls (Fig 6B).
Treatment with the inhibitor also decreased the recruitment of
neutrophils to the kidney (Fig 6C). We confirmed this using the
intraperitoneal C. albicans infection model and found that only the
treatment with BIRB796 led to a significant reduction in peritoneal
neutrophil recruitment compared to control mice treated with
either DMSO or SB203580 (Fig 6D). Thus, p38c/p38d inhibition
enhances antifungal immunity and might protect from C. albicans
sepsis.
Discussion
In this study, we address the role of p38c/p38d in candidiasis and
show their importance in the regulation of innate antifungal immu-
nity. We found that deletion of p38c/p38d has a beneficial effect
improving survival in C. albicans-infected mice, and that p38c/p38d
deficiency in myeloid cells is fundamental for this phenotype.
Macrophages influence the inflammatory environment by modu-
lating the production of cytokines and chemokines during fungal
infection (Ersland et al, 2010), and p38c/p38d deletion limited the
intrinsic response of BMDM to C. albicans by diminishing the
production of cytokines and chemokines. Upon fungus recognition,
the stimulation of macrophage receptors triggers the activation of
signalling pathways, such as the ERK1/2 pathway, which induce the
expression of immune modulators. Here, we show that, in addition
to their role in TLR signalling, TAK1-IKKb-TPL2 contribute to
Dectin-1-mediated signalling in mouse BMDM, being essential for
ERK1/2 activation. Upon Dectin-1 stimulation, the protein Syk is
recruited to the receptor, which triggers the assembly of the
complex CARD9/BCL-10/MALT1 (CMB; Geijtenbeek & Gringhuis,
2009). It has been shown that the CBM complex activates the IKK
pathway by recruiting and activating the protein E3 ubiquitin ligase
TNF receptor-associated factor 6 (TRAF6), which is essential for
TAK1 activation (Geijtenbeek & Gringhuis, 2009; Cohen, 2014). We
therefore propose the existence of a Syk-CMB-TRAF6-TAK1-IKKb-
TPL2-MKK1-ERK1/2 pathway in macrophages, which is activated
by Dectin-1 engagement and regulated by p38c/p38d (Fig 2G).
Contrary to what happens in p38c/p38d-deficient mice, the lack
of TPL2 does not affect the survival of C. albicans-infected mice,
nor reduce kidney fungal load or cytokine production, suggesting
that p38c/p38d signalling controls systemic candidiasis in vivo inde-
pendently of TPL2. This result was unexpected since in macro-
phages the combined deletion of p38c and p38d decreases the
steady-state levels of TPL2 and therefore the activation of ERK1/2
downstream of TLR and Dectin-1, which has a central role in cyto-
kine production (Risco et al, 2012; Arthur & Ley, 2013). Nonethe-
less, this finding is supported by previous reports in which p38c/
p38d deletion does not recapitulate the effect observed in TPL2/
mice. In an azoxymethane/dextran sodium sulphate (AOM/DSS)
colitis-associated colon cancer model, TPL2 deficiency increases the
development of tumours in mice compared to WT mice, whereas in
p38c/d/ mice tumour development is decreased (Koliaraki et al,
2012; Del Reino et al, 2014). The role of TPL2 in candidiasis has not
been addressed so far, and further studies using TPL2-deficient mice
are required to determine its specific function in fungal infection.
Additionally, it is possible that p38c/p38d, and also TPL2, have dif-
ferent or even opposite functions depending on the cell type or
context, which would affect the general outcome in the response to
C. albicans infection. This idea is supported by the observation that:
(i) the reduction in both cytokine production and leucocyte recruit-
ment is significantly more pronounced in LysM-p38c/d/ than in
p38c/d/ mice; (ii) cytokine production is reduced by pharmaco-
logical TPL2 inhibition in macrophages but not in TPL2-deficient
mice infected with C. albicans; and (iii) the production of TNFa and
IL-6 is reduced in p38c/d/-infected mice, but not in p38c/d/-
infected macrophages, suggesting that the expression levels of these
molecules in infected mice are indirectly regulated by p38c/d in
myeloid cells acting on other cell types.
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Figure 4. Reduced inflammation in p38c/d/ mice in response to Candida albicans infection.
A WT, p38c/d/ and LysM-p38c/d/ mice were intravenously infected with 1 × 105 CFU C. albicans and at days 1 and 3 post-infection, relative TNFa, IL-6 and IL-1b
mRNA expression in the kidney was determined by qPCR and normalized to b-actin mRNA. Each symbol represents an individual mouse. Figure shows mean  SEM
(n = 5–8). ns, not significant, *P ≤ 0.05, **P ≤ 0.01 relative to WT mice. Parametric, unpaired t-test.
B Kidney cells from 0-, 1- and 3-day C. albicans-treated WT, p38c/d/ and LysM-p38c/d/ mice as in (A) were stained with anti-CD45, -Ly6G and -F4/80 antibodies
and positive cells analysed by flow cytometry. CD45+ cells were gated and -F4/80+ and -Ly6G+ cells analysed by flow cytometry. Representative profiles are shown.
Each symbol represents an individual mouse (two to three independent experiment). Figure shows mean  SEM (n = 5–14 mice/condition), ns, not significant;
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, relative to WT kidney cells, at each time point. Parametric, unpaired t-test.
C Mice were intraperitoneally infected with 5 × 106 CFU C. albicans, and at day 1 post-infection, peritoneal cells were stained and analysed as in (B). Representative
profiles are shown. Each symbol represents an individual mouse. Figure shows mean  SEM (n = 4), ns not significant; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, relative to
WT kidney cells. Parametric, unpaired t-test.
D Mice were infected with C. albicans as in (A), relative MIP-2, KC and CCL2 mRNA expression in the kidney was determined by qPCR as in (A). Each symbol represents
an individual mouse. Figure shows mean  SEM (n = 3–5). ns, not significant, *P ≤ 0.05, **P ≤ 0.01 relative to WT mice. Parametric, unpaired t-test.
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The lower susceptibility of p38c/d/ and LysM-p38c/d/ mice
to systemic infection with C. albicans is likely due to the decreased
fungal growth in their kidneys. The kidney fungal load correlates
with the severity of renal failure and the associated progressive
sepsis, which finally is the cause of death in this model (Spellberg
et al, 2005). One important finding of the present study is that the
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Figure 5. p38c/p38d regulate antifungal activity against Candida albicans.
A BMDM from WT or p38c/d/ mice were exposed for the indicated times to 1 × 106 CFU/ml HK-Ca. Relative iNOS mRNA expression was determined by qPCR. Data
show mean  SEM from one representative experiment of two in triplicate, with similar results. *P ≤ 0.05, ***P ≤ 0.001 relative to WT BMDM. Parametric,
unpaired t-test.
B ROS production in BMDM co-cultured with 1 × 106 CFU C. albicans. Experiments were performed in triplicate. RLU, relative light unit.
C Candida albicans killing by BMDM. The results are represented as percentage of killing (the percentage of killed fungal cells among the phagocytosed fungus). The
C. albicans/BMDM ratio was 1:10. Values are mean  SEM (n = 6); ***P ≤ 0.001 relative to WT cells. Parametric, unpaired t-test.
D ROS production in neutrophils isolated from blood of WT or p38c/d/ mice after infection. Neutrophils were stimulated with 1.5 × 106/ml HK-Ca. Experiments
were performed in triplicate.
E Candicidal activity of neutrophils determined as in (C). Values are mean  SEM (n = 4); *P ≤ 0.05 relative to WT cells. Parametric, unpaired t-test.
F, G ROS production without (F) or with (G) re-stimulation with C. albicans in intraperitoneal immune cell infiltrates of WT or p38c/d/ mice 1 day after
intraperitoneal C. albicans infection (5 × 106 CFU, n = 4 mice per group).
H WT and p38c/d/ mice were intravenously infected with 1 × 105 CFU C. albicans. Relative iNOS mRNA expression in the kidney was determined by qPCR and
normalized to b-actin mRNA. Each symbol represents an individual mouse. Figure shows mean  SEM (n = 3–5). Only significant results are indicated, *P ≤ 0.05,
relative to WT mice. Parametric, unpaired t-test.
I WT and p38c/d/ mice were infected with 1 × 105 CFU C. albicans and treated with 200 mg/kg body weight per day of N-acetylcysteine (NAC) from SIGMA or
with the same volume of the vehicle PBS for 5 days [WT + CA + NAC (n = 8); p38c/d/ + CA + NAC (n = 8)]. Control groups of WT and p38c/d/ mice treated
with 200 mg/kg body weight per day of NAC were included to check its toxicity [WT + NAC (n = 10); p38c/d/ + NAC (n = 10)]. Control groups of WT and
p38c/d/ mice infected with C. albicans were also included for comparison [WT + CA (n = 8); p38c/d/ + CA (n = 8)]. Survival was monitored as indicated. Data
are presented as a Kaplan–Meier plot. ns, not significant, *P ≤ 0.05; **P ≤ 0.01. Two-way ANOVA using GraphPad Prism software.
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Figure 6. Treatment with p38c/p38d inhibitor shows antifungal effects in vivo.
A WT mice were intravenously injected with 1 × 105 CFU of Candida albicans and treated with 10 mg BIRB796 or SB203580 per kg body weight per day, or with the
same volume of the vehicle DMSO. Kidney fungal load was determined 3 days after infection. ns, not significant, *P ≤ 0.05 (n = 5 mice/condition). Each symbol
represents an individual mouse. Parametric, unpaired t-test.
B Mice were treated as in (A) and iNOS mRNA levels in the kidney measured 3 days after infection by qPCR. Each symbol represents an individual mouse. Figure shows
mean  SEM (n = 5 mice/condition). ns, not significant, *P ≤ 0.05. Parametric, unpaired t-test.
C Neutrophil infiltration in the kidney of infected WT mice, treated with BIRB796 or SB203580 inhibitor as in (A) was determined by flow cytometry. Each symbol
represents an individual mouse. Figure shows mean  SEM (n = 6 mice/condition), ns not significant; ***P ≤ 0.001. Parametric, unpaired t-test.
D Mice were intraperitoneally infected with 5 × 106 CFU C. albicans and treated with 10 mg/kg body weight per day BIRB796 or SB203580, or with the same volume of
the vehicle DMSO. Neutrophil infiltration in the peritoneum was measured by flow cytometry at day 1 post-infection. Each symbol represents an individual mouse.
Figure shows mean  SEM (n = 4 mice/condition), ns, not significant; *P ≤ 0.05, **P ≤ 0.01. Parametric, unpaired t-test.
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production of cytokines such as IL-6, TNFa, IFNc, and IL-1b, in
p38c/ddeficient mice is significantly lower than in WT animals in
response to C. albicans. p38c/p38d deletion also impaired the
production of the neutrophil and macrophage chemoattractants
CCL2, KC and MIP-2 (Soehnlein & Lindbom, 2010), which paralleled
the decrease in leucocyte recruitment to the infected kidneys, partic-
ularly of neutrophils. It has been shown that pharmacological
suppression of monocytes and neutrophils with the compound
pioglitazone, a nuclear receptor peroxisome proliferator-activated
receptor-c (PPAR-c) agonist, led to increased survival and reduced
immunopathology of C. albicans-infected mice (Majer et al, 2012),
in agreement with our results. Thus, the decrease in inflammatory
molecule production observed in p38c/p38d-deficient mice might
contribute to the increase in mouse survival as our results from the
treatment with the antiinflammatory drug ibuprofen indicate.
Perhaps the reduced acute inflammatory response in p38c/d/mice
is more successful in allowing the elimination of the fungus and
preventing kidney damage. However, alternative explanations could
be considered. One such explanation may envisage the lower
inflammation to be due to the lower fungal loads in the kidneys as a
result of the successful early elimination of the pathogen. Effects of
p38c/d on inhibitory cell populations with deleterious roles during
candidiasis, such as T-regulatory cells (Netea et al, 2008), can also
be considered since p38c/p38d deletion slightly decreased the
recruitment of CD4+ cells in the kidney of infected mice. The poten-
tial effects of p38c/d in the activation of T-regulatory cells are
unknown and require investigation in future studies.
The inhibitory effects of p38c/p38d on myeloid cells killing
mechanisms, such as ROS production or iNOS expression, might
also contribute to the protection to C. albicans infection observed in
p38c/p38d-deficient mice. Macrophages and neutrophils are impor-
tant not only for building an inflammatory environment, but also
for the fungal clearance to achieve an efficient protection against
systemic candidiasis (Netea et al, 2008). A balance between the
beneficial immune response that kills the pathogen and an exacer-
bated inflammation with negative effects is essential for the resolu-
tion of the infection without causing tissue damage in the host. Our
data show that at an early phase (day 1) of C. albicans infection the
loss of p38c/p38d does not affect fungal burden in the kidney,
whereas, at a later phase of infection (day 3) fungal burden is lower
in p38c/p38d-deficient mice than in control WT. These results indi-
cate that p38c/p38d deletion favours fungal clearance in systemic
candidiasis, which correlates with the increased killing capacity,
ROS production and iNOS mRNA levels observed in p38c/p38d-null
cells and mice compared to control WT. Accordingly, a decrease in
ROS levels caused by the treatment with the antioxidant agent NAC
correlates with a decrease in C. albicans killing by macrophages
in vitro and a reduction in mice survival in vivo. These observations
suggest that the lack of p38c/p38d facilitates fungus elimination by
phagocytic cells, which would control fungal growth in the kidney,
limiting the inflammatory immune response and improving mouse
survival after fungal infection.
The in vivo inhibition of p38c/p38d with the compound BIRB796
mimicked the loss of these kinases, with regard to fungal burden
and iNOS production in the kidney, as well as to the recruitment of
neutrophils in the kidneys and the peritoneum after C. albicans
infection. This reveals the potential value of p38c/p38d inhibitors as
effective antifungal agents and also indicates the importance of the
development of potent and specific p38c/p38d inhibitors as an alter-
native to traditional p38a inhibitors. In prolonged treatments, p38a
inhibitors have proven to be minimally effective due to liver toxicity
or to increased inflammation due to the failure of p38a-mediated
negative regulation of TAK1 (Gaestel et al, 2009).
In summary, our work adds knowledge into the understanding of
the molecular mechanisms responsible for the host defence against
C. albicans infection and provides evidence that p38c/p38d play an
important role in the control of fungal infection at two different but
interconnected levels: the potentially harmful host acute inflamma-
tory response and the beneficial host immune response that elimi-
nates the Candida. These two processes modulate each other.
Considering the complexity of C-type lectin receptor signalling and
that the incidence of Candida species infections and the relapse
episodes after antifungal treatment have increased in recent decades
(Brown et al, 2012), further studies of p38c/p38d-associated signal-
ling pathways would offer novel strategies for the design of more
effective agents against fungal infections.
Materials and Methods
Mice
All mice (13–18 weeks old female) were housed in specific
pathogen-free conditions in the CNB-CSIC animal house, and all
animal procedures were performed in accordance with national and
EU guidelines, with the approval of the Centro Nacional de Biotec-
nologı´a Animal Ethics Committee, CSIC and Comunidad de Madrid
(Reference: CAM PROEX 316/15).
C57BL/6J TPL2+/+ and C57BL/6J TPL2/ littermates were
produced from heterozygous mice (Rodriguez et al, 2008). C57BL/
6J WT, p38c/dflox/flox, p38c/d/ and LysM-Cre+/-p38c/dflox/flox
(called here LysM-Crep38c/d/) mice have been described (Risco
et al, 2012; Zur et al, 2015). Double knockout mice have been used
instead of single knockout mice because each of these p38MAPKs
normally compensates the loss of the other in many biological
processes (Esco´s et al, 2016). WT and p38c/dflox/flox mice have been
used in all the in vivo experiments as control, with similar results.
WT, LysM-Cre+/ and p38c/dflox/flox mice were used as control
when cell recruitment was analysed in the intraperitoneal C. albi-
cans model. The recruitment of F4/80+ and Ly6G+ cells in this
model was similar in all mouse lines (Appendix Fig S8). Mouse
genotypes were determined by PCR. All strains were backcrossed
onto the C57BL/6 strain for at least nine generations.
Antibody
The description of all the antibodies and the dilution used in this
study is provided in Appendix Table S1.
Candida albicans infection
Candida albicans (strain SC5314) was grown on YPD agar plates at
30°C for 48 h. Eight- to 12-week-old female mice were infected
intravenously with 1 × 105 colony-forming units (CFU) of C. albi-
cans and monitored daily for weight and survival. Kidney fungal
burden was determined at indicated times post-infection by plating
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the kidney homogenates in serial dilutions on YPD agar plates. After
48 h, CFU were counted. Kidneys from infected mice were fixed in
4% formalin and embedded in paraffin. Serial sections were
examined microscopically after staining with periodic acid Schiff
(PAS) and haematoxylin–eosin.
Bone marrow-derived macrophages (BMDM) and stimulation
BMDM were isolated and cultured as described in Appendix Supple-
mentary Methods (Risco et al, 2012). BMDM were stimulated with:
1 × 106/ml HK-Ca, 10 lg/ml Zymosan, 5 lg/ml Imiquimod-R837,
200 ng/ml Pam3Cys, 200 ng/ml Poly I-C, 250 ng/ml ODN-1668
(InvivoGen); 10 lg/ml Curdlan (a water-insoluble b-1,3 polysaccha-
ride from Alcaligenes faecalis), 100 ng/ml LPS, 100 ng/ml PMA
(Sigma). Where indicated, cells were pre-treated with DMSO,
SB203580, BIRB0796, C34; PD184352; PRT062607; BI605906; Sora-
fenib (Bay 43-9006) or NG25. Cells were lysed as described in
Appendix Supplementary Methods. For mRNA expression analysis,
cells were lysed with NZYol (NZYtech) and RNA extracted using a
standard protocol with chloroform–isopropanol–ethanol.
Neutrophil isolation
Neutrophils were obtained from adult WT and p38c/d/ mice
blood followed by hypotonic red blood cell lysis as described in
Appendix Supplementary Methods.
Isolation and stimulation of human monocytes
This protocol is described in Appendix Supplementary Methods.
Informed consent was obtained from all healthy volunteers. The
experiments conformed to the principles set out in the WMA Decla-
ration of Helsinki and the Department of Health and Human
Services Belmont Report.
Phagocytosis and killing of Candida albicans by macrophages
and neutrophils
BMDM and neutrophils were obtained, and phagocytosis and killing
were performed using the method described earlier (Vonk et al,
2012) at a Candida/BMDM or Candida/neutrophils ratio of 1:10.
Measurement of reactive oxygen species production
Production of ROS was measured with an assay using luminol as
the probe in real time over 220 min. 75,000 neutrophils or 500,000
BMDM or peritoneal cells were plated in 200 ll culture medium
(0.05% FBS in HBSS) on a 96-well sterile luminometer plate (Costar,
Corning, NY). Cells were stimulated or not as indicated, and L-012
(Wako Chemicals, Osaka, Japan) was incorporated to the medium
(7.75 lg/well final concentration) at the beginning of the stimula-
tion. Chemiluminescence was measured at 1-min intervals and
expressed as relative light units (RLU).
Statistical analysis
In vitro experiments have been performed at least twice with three
independent replicates per experiment. For the analysis of mouse
survival, production of inflammatory molecules, cell recruitment
and CFU in the kidney, the size of the groups was established
according to the Spanish ethical legislation for animal experiments.
At least 4–5 mice per group were used. Differences in mouse
survival were analysed by two-way ANOVA using GraphPad Prism
software. Other data were analysed using Student’s t-test. In all
cases, P-values < 0.05 were considered significant. Data are shown
as mean  SEM. The exact n and P-values are given in
Appendix Tables S2 and S3.
Expanded View for this article is available online.
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The paper explained
Problem
Candida infections cause high mortality in immunocompromised
patients. Sepsis caused by C. albicans is one of the most frequent in
hospital intensive care units in patients with AIDS or auto-immune
diseases and in those undergoing anti-cancer chemotherapy or organ
transplantation. Recent studies have shown the important roles of
p38c and p38d (p38c/p38d) in regulating cytokine production, T-cell
activation or immune cell recruitment in arthritis and colitis, and in
tumorigenesis associated with inflammation. While several studies
have demonstrated that p38c/p38d are involved in inflammatory
processes, the role of these kinases in C. albicans infection is comple-
tely unknown. Therefore, we hypothesized that p38c/p38d might regu-
late disseminated candidiasis.
Results
We show that p38c/p38d control cytokine production in response to
C. albicans in macrophages (mediated by Dectin-1 and TLR receptors)
and describe a novel signalling pathway downstream of Dectin-1,
which is regulated by p38c/p38d. Furthermore, using a mouse model
of systemic candidiasis, we found that the deletion of p38c/p38d in
myeloid cells protected against C. albicans infection. Mechanistically,
we found that p38c/p38d deletion increased antifungal killing capacity
of neutrophils and macrophages mediated by increased NOS expres-
sion and ROS production in these phagocytes. In addition, p38c/p38d
deficiency decreased macrophage and neutrophil recruitment to
infected kidneys and reduced the production of cytokines and chemo-
kines. We also demonstrate that chemical inhibition of p38c/p38d
in vivo exerts antifungal therapeutic effects in mice infected with
C. albicans.
Impact
Our findings define a major role for p38c/p38d in C. albicans infection
and underscore their importance in regulating inflammatory
processes. Our observations point out p38c/p38d as potential targets
for the development of novel antifungal drugs for human disease and
suggest that therapies aimed to inhibit p38c/p38d might significantly
reduce candidiasis.
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